Indeed, deletion of CD11b or Let7a suppression increases the PDGF-BB/VEGF-A ratio, resulting in tumors with normalized vessels that stimulate tumor growth but are susceptible to cancer chemotherapy. Here, VEGFA is linked to cancer.